Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence
Open Access
- 1 August 2006
- journal article
- Published by American Society of Hematology in Blood
- Vol. 108 (3) , 1021-1029
- https://doi.org/10.1182/blood-2006-01-0067
Abstract
The antiviral thymidine analog azidothymidine (AZT) is used to treat several virus-associated human cancers. However, to date the mechanism of AZT action remains unclear and thus, reasons for treatment failure are unknown. Adult T-cell leukemia/lymphoma (ATL) is an aggressive malignancy of poor prognosis. Here, we report that enduring AZT treatment of T-cell leukemia virus I–infected cells, in vitro and in vivo in ATL patients, results in inhibition of telomerase activity, progressive telomere shortening, and increased p14ARF expression. In turn, this elicits stabilization and reactivation of the tumor suppressor p53-dependent transcription, increased expression of the cyclin-dependent kinase inhibitor p21Waf1, and accumulation of p27kip1, thereby inducing cellular senescence and tumor cell death. While ATL patients carrying a wild-type p53 enter remission following treatment with AZT, those with a mutated p53 did not respond, and patients9 disease relapse was associated with the selection of a tumor clone carrying mutated inactive p53.Keywords
This publication has 75 references indexed in Scilit:
- Azidothymidine inhibits NF-κB and induces Epstein-Barr virus gene expression in Burkitt lymphomaBlood, 2005
- Evidence for NF-κB- and CBP-Independent Repression of p53's Transcriptional Activity by Human T-Cell Leukemia Virus Type 1 Tax in Mouse Embryo and Primary Human FibroblastsJournal of Virology, 2005
- Telomerase activity and telomere length as prognostic factors of adult T-cell leukemiaLeukemia & Lymphoma, 2005
- HTLV-I Tax induces a novel interaction between p65/RelA and p53 that results in inhibition of p53 transcriptional activityBlood, 2004
- Short Communication: Telomerase Activity of Human Peripheral Blood Mononuclear Cells in the Course of HTLV Type 1 Infection in VitroAIDS Research and Human Retroviruses, 2002
- Induction of a TRAIL mediated suicide program by interferon alpha in primary effusion lymphomaOncogene, 2001
- Inactivation of p53 by HTLV Type 1 and HTLV Type 2 Taxtrans-ActivatorsAIDS Research and Human Retroviruses, 2000
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992
- Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease.Proceedings of the National Academy of Sciences, 1982
- Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphomaProceedings of the National Academy of Sciences, 1980